论文部分内容阅读
应用血管扩张剂是治疗心力衰竭的重要进展。巯甲丙脯酸是血管紧张素转化酶抑制剂,它能抑制血管紧张素Ⅱ的生成并减轻钠、水潴留。现已广泛应用于高血压及心力衰竭的治疗。我科自1988年9月至1990年3月对18例经综合治疗效果不显的充血性心力衰竭病人应用巯甲丙脯酸治疗,取得了较好的疗效。此文,就临床疗效及副作用进行了重点观察,现报道如下:(全部药品由中美上海施贵宝制药有限公司提供)。临床资料 1、病例选择: 全组共18例。其中风心病11例,冠心病
Application of vasodilators is an important advance in the treatment of heart failure. Captopril is an angiotensin-converting enzyme inhibitor that inhibits angiotensin II production and reduces sodium and water retention. Is now widely used in the treatment of hypertension and heart failure. Our department from September 1988 to March 1990 on the 18 cases of comprehensive treatment of patients with congestive heart failure was not obvious using captopril treatment, and achieved good results. This article, the clinical efficacy and side effects were highlighted, are reported as follows: (All drugs provided by the Sino-US Shanghai Squibb Pharmaceutical Co., Ltd.). Clinical data 1, case selection: a total of 18 cases. Including rheumatic disease in 11 cases, coronary heart disease